Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2
about
sameAs
Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytesThe crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studiesLaser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells.Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pairMolecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis.Virus receptors: implications for pathogenesis and the design of antiviral agents.Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.Epstein-Barr virus entry.Characterization of an Epstein-Barr virus receptor on human epithelial cells.Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus.Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220.Structure of the Epstein-Barr virus major envelope glycoprotein.Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.Cutaneous anaplastic T-cell lymphoma in a patient with human immunodeficiency virus infection: detection of Epstein-Barr virus DNA.Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).Mapping of the primary binding site of measles virus to its receptor CD46.A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice.
P2860
Q24296010-87F4701E-9847-4408-95EF-8E9D74B8482AQ24680369-3F04D337-C799-420F-A728-CA4DC51B4934Q27639376-F2BF118E-77F4-42E2-8C2A-62C806CAF935Q30176620-D99487AB-98CD-47DC-80E1-0708F4C7B93FQ33360874-AE9A3254-37FC-4255-8212-55CD4CDC0704Q33402381-F3F57181-6B37-4477-BABF-7D0B87F23EFAQ34094547-F16D752F-119D-43DA-B49B-67256E287034Q34597080-B458B485-8605-4A8B-84C1-89B9F536E206Q34765617-EDBD1852-5203-4665-B5F4-D34E30D7CD8DQ35366667-288CE3ED-A3E1-4B1F-8CD3-2E43E1C618DBQ35871457-DD6B5D35-258C-40C7-AA1A-F86DFD881BF2Q35947541-CCCBD561-C1BB-4A75-BD3A-C74CDDDBBCA4Q36231943-E9D63886-EEA5-411E-B884-922F9B357A07Q36623632-97A206D3-DE21-4BF7-8601-EAEEFD96F140Q36645449-5474F4F3-4659-4504-94BB-B92A5C7BE0E3Q36945442-237EDDC1-3909-4FE7-BE4F-4CF7BAC1BCF1Q36979271-51833060-F6EC-414E-A392-FE37E8C5AC80Q39871551-60FC0B67-0B62-4A52-BBEC-080FBED46A30Q39873174-889CDDE0-45C4-48D7-AC9E-4415A3FD3BE8Q40214421-1AF8E90B-8784-4728-A5DD-BCE697788A08Q42633344-3EFDC779-0D5C-40AB-9A7E-4B2CD55D59BCQ43670282-71E514F0-D132-4B82-9C0A-5EE12F2A7F8DQ45399777-95DC4EBA-D378-4701-827A-FA9E22FE0A50Q45760982-1EDCFD57-0668-485E-BB1B-0F55F849DA17Q47669801-71818750-C58D-4897-96EB-3AB63D7195B2
P2860
Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Determination of the structura ...... man complement receptor type 2
@ast
Determination of the structura ...... man complement receptor type 2
@en
Determination of the structura ...... man complement receptor type 2
@nl
type
label
Determination of the structura ...... man complement receptor type 2
@ast
Determination of the structura ...... man complement receptor type 2
@en
Determination of the structura ...... man complement receptor type 2
@nl
prefLabel
Determination of the structura ...... man complement receptor type 2
@ast
Determination of the structura ...... man complement receptor type 2
@en
Determination of the structura ...... man complement receptor type 2
@nl
P2093
P2860
P356
P1476
Determination of the structura ...... man complement receptor type 2
@en
P2093
P2860
P304
P356
10.1084/JEM.174.6.1299
P407
P577
1991-12-01T00:00:00Z